Kliničke studije za Ekcem u državi Alabama
6 studija za Ekcem traži sudionike na lokacijama u državi Alabama.
Gradovi u državi Alabama
Službeni tekst studije (engleski)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT06947993First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07527923A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
U tijeku regrutacijaFaza 3
Od 6 do 11 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06807268A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Cahaba Dermatology & Skin Health Center, Birmingham
U tijeku regrutacijaFaza 3
Od 2 do 11 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06807281A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 28. kol 2026. · NCT07599813A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Allervie Clinical Research, Birmingham
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 4. svi 2026. · NCT05995964Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.